Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karin Haustermans

Showing results (211-220 of 285) with videos related to

Pageof 29
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|October 7, 2020
Optimal <sup>68</sup>Ga-PSMA and <sup>18</sup>F-PSMA PET window levelling for gross tumour volume delineation in primary prostate cancerCédric Draulans, Robin De Roover, Uulke A van der Heide, et al.
International Journal of Radiation Oncology, Biology, Physics|September 19, 2023
Risk Modeling for Individualization of the FLAME Focal Boost Approach in External Beam Radiation Therapy for Patients With Localized Prostate CancerKarolína Menne Guricová, Veerle Groen, Floris Pos, et al.
International Journal of Radiation Oncology, Biology, Physics|July 21, 2005
Molecular markers predicting radiotherapy response: report and recommendations from an International Atomic Energy Agency technical meetingCatharine M L West, Michael J McKay, Tobias Hölscher, et al.
International Journal of Radiation Oncology, Biology, Physics|August 8, 2016
Predicting the 5-Year Risk of Biochemical Relapse After Postprostatectomy Radiation Therapy in ≥PT2, pN0 Patients With a Comprehensive Tumor Control Probability ModelClaudio Fiorino, Sara Broggi, Nicola Fossati, et al.
European Journal of Cancer (Oxford, England : 1990)|December 31, 2025
Long-term recurrence patterns in rectal cancer after neoadjuvant therapy: 25-years of real-world dataPieter Maerten, Gilles Defraene, Albert Wolthuis, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 3, 2024
Stereotactic body radiotherapy with a focal boost to the intraprostatic tumor for intermediate and high risk prostate cancer: 5-year efficacy and toxicity in the hypo-FLAME trialCédric Draulans, Karin Haustermans, Floris J Pos, et al.
EJNMMI Research|August 7, 2013
18F-MK-9470 PET imaging of the type 1 cannabinoid receptor in prostate carcinoma: a pilot studyKimy M Emonds, Michel Koole, Cindy Casteels, et al.
Radiation Oncology (London, England)|February 12, 2026
Patterns of care and outcome of liver SBRT: results from a multicentre National quality projectPieter Deseyne, Geert Silversmit, Nicolas Jansen, et al.
Cancer Research|December 9, 2017
Radiotherapy-Activated Cancer-Associated Fibroblasts Promote Tumor Progression through Paracrine IGF1R ActivationJoke Tommelein, Elly De Vlieghere, Laurine Verset, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 21, 2021
ESTRO ACROP guidelines for the delineation of lymph nodal areas in upper gastrointestinal malignanciesVincenzo Valentini, Francesco Cellini, Angela Riddell, et al.
Pageof 29

Showing results (211-220 of 285) with videos related to

Sort By:
Pageof 29
European Journal of Nuclear Medicine and Molecular Imaging|October 7, 2020
Optimal <sup>68</sup>Ga-PSMA and <sup>18</sup>F-PSMA PET window levelling for gross tumour volume delineation in primary prostate cancerCédric Draulans, Robin De Roover, Uulke A van der Heide, et al.
International Journal of Radiation Oncology, Biology, Physics|September 19, 2023
Risk Modeling for Individualization of the FLAME Focal Boost Approach in External Beam Radiation Therapy for Patients With Localized Prostate CancerKarolína Menne Guricová, Veerle Groen, Floris Pos, et al.
International Journal of Radiation Oncology, Biology, Physics|July 21, 2005
Molecular markers predicting radiotherapy response: report and recommendations from an International Atomic Energy Agency technical meetingCatharine M L West, Michael J McKay, Tobias Hölscher, et al.
International Journal of Radiation Oncology, Biology, Physics|August 8, 2016
Predicting the 5-Year Risk of Biochemical Relapse After Postprostatectomy Radiation Therapy in ≥PT2, pN0 Patients With a Comprehensive Tumor Control Probability ModelClaudio Fiorino, Sara Broggi, Nicola Fossati, et al.
European Journal of Cancer (Oxford, England : 1990)|December 31, 2025
Long-term recurrence patterns in rectal cancer after neoadjuvant therapy: 25-years of real-world dataPieter Maerten, Gilles Defraene, Albert Wolthuis, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 3, 2024
Stereotactic body radiotherapy with a focal boost to the intraprostatic tumor for intermediate and high risk prostate cancer: 5-year efficacy and toxicity in the hypo-FLAME trialCédric Draulans, Karin Haustermans, Floris J Pos, et al.
EJNMMI Research|August 7, 2013
18F-MK-9470 PET imaging of the type 1 cannabinoid receptor in prostate carcinoma: a pilot studyKimy M Emonds, Michel Koole, Cindy Casteels, et al.
Radiation Oncology (London, England)|February 12, 2026
Patterns of care and outcome of liver SBRT: results from a multicentre National quality projectPieter Deseyne, Geert Silversmit, Nicolas Jansen, et al.
Cancer Research|December 9, 2017
Radiotherapy-Activated Cancer-Associated Fibroblasts Promote Tumor Progression through Paracrine IGF1R ActivationJoke Tommelein, Elly De Vlieghere, Laurine Verset, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 21, 2021
ESTRO ACROP guidelines for the delineation of lymph nodal areas in upper gastrointestinal malignanciesVincenzo Valentini, Francesco Cellini, Angela Riddell, et al.
Pageof 29